Shell Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-19,118
Closed -$40K 1427
2022
Q1
$40K Sell
19,118
-2,874
-13% -$7K ﹤0.01% 1352
2021
Q4
$82K Sell
21,992
-388
-2% -$1.67K ﹤0.01% 1340
2021
Q3
$112K Sell
22,380
-870
-4% -$5.01K ﹤0.01% 1296
2021
Q2
$152K Hold
23,250
﹤0.01% 1297
2021
Q1
$160K Buy
+23,250
New +$197K ﹤0.01% 1201

Other funds holding PGEN

Shell Asset Management's PGEN Position: Q2 2022 in Review

Shell Asset Management sold out of Precigen (PGEN) in Q2 2022, closing a stake of 19,118 shares — an estimated $40K sold.

Shell Asset Management first reported a position in PGEN in Q1 2021 and held it in 5 quarters. The position peaked at $160K in Q1 2021. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Shell Asset Management reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Shell Asset Management sold 19,118 Precigen shares in Q2 2022, an estimated $40K.
  • Shell Asset Management first reported a position in Precigen in Q1 2021 and held it in 5 quarters.
  • Shell Asset Management's Precigen position peaked at $160K in Q1 2021.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Shell Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.